Johnson & Johnson's "misleading marketing and promotion" of opioids created a nuisance that compromised the health and safety of thousands of Oklahomans, an Oklahoma judge ruled Monday. In a first-of-its-kind case, Judge Thad Balkman ordered J&J to pay more than $572 million to immediately abate the nuisance he said the company and its subsidiary, Janssen Pharmaceuticals Inc., caused. "The opioid crisis is an imminent danger and menace to Oklahomans ... This is a temporary public nuisance that can be abated," Balkman said.